Over 25 companies are developing products for intervertebral disc repair and restoration, which signifies the clinical unmet need of this spinal disease.
The introduction of next-generation technologies promises to reshape clinical practice and greatly expand options for patients who suffer from cartilage defects and degenerative joint disease.